Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line

Cancer Letters

Volumn 260, Issue 1-2, 2008, Pages 37-47

  Persson, Fredrik ^a   Olofsson, Anita ^a   Sjögren, Helene ^a   Chebbo, Nihal ^a   Nilsson, Bengt ^a   Stenman, Göran ^a   Åman, Pierre ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Array CGH; Cell cycle regulation; Gene amplification; HMGA2; MDM2; Well differentiated liposarcoma

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; HIGH MOBILITY GROUP A2 PROTEIN; PROTEIN MDM2; RNA;

ADRENALECTOMY; AGED; AMPLICON; ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CASE REPORT; CELL CYCLE; CHROMOSOME; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 1Q; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DNA BINDING; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GOT3 CELL LINE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LIPOSARCOMA; MARKER CHROMOSOME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE CULTURE;

AGED; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 13; CYTOGENETIC ANALYSIS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; LIPOSARCOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETROPERITONEAL NEOPLASMS; SPECTRAL KARYOTYPING;

EID: 38349026317     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.10.032     Document Type: Article

References (45)

1. Dei Tos A.P., Doglioni C., Piccinin S., Sciot R., Furlanetto A., Boiocchi M., et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J. Pathol. 190 (2000) 531-536
2. Dei Tos A.P., and Pedeutour F. Atypical lipomatous tumour/well differentiated liposarcoma; dedifferentiated liposarcoma. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). Tumors of Soft Tissue and Bone. WHO Classification of Tumours Pathology and Genetics (2002), IARC Press, Lyon 35-37 38-39
3. Pedeutour F., and Foa C. From cytogenetics to cytogenomics of adipose tissue tumors: 1. Benign adipose tissue tumors. Bull. Cancer 89 (2002) 689-695
4. Pedeutour F., Suijkerbuijk R.F., Forus A., Van Gaal J., Van de Klundert W., Coindre J.M., et al. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer 10 (1994) 85-94
5. Pedeutour F., Forus A., Coindre J.M., Berner J.M., Nicolo G., Michiels J.F., et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24 (1999) 30-41
6. Gisselsson D., Höglund M., Mertens F., Mitelman F., and Mandahl N. Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization. Genes Chromosomes Cancer 23 (1998) 203-212
7. F. Mitelman, B. Johansson, F. Mertens (Eds.), Mitelman Database of Chromosome Aberrations in Cancer. Available from: , 2007.
8. Sirvent N., Forus A., Lescaut W., Burel F., Benzaken S., and Chazal M. Characterization of centromere alterations in liposarcomas. Genes Chromosomes Cancer 29 (2000) 117-129
9. Kresse S.H., Berner J.M., Meza-Zepeda L.A., Gregory S.G., Kuo W.L., Gray J.W., et al. Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH. Mol. Cancer 4 (2005) 39
10. Crozat A., Åman P., Mandahl N., and Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363 (1993) 640-644
11. Meis-Kindblom J.M., Sjögren H., Kindblom L.G., Peydro-Mellquist A., Röijer E., Åman P., et al. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis. Virchows Arch. 439 (2001) 141-151
12. Engström K., Willen H., Kåbjörn-Gustafsson C., Andersson C., Olsson M., Göransson M., et al. The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells. Am. J. Pathol. 168 (2006) 1642-1653
13. L.G. Shaffer, N. Tommerup (Eds.), ISCN, An International system for human cytogenetic nomenclature, S Karger, Basel, 2005.
14. 2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21). Cancer Res. 60 (2000) 6832-6835
15. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
16. Barrett M.T., Scheffer A., Ben-Dor A., Sampas N., Lipson D., Kincaid R., et al. Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc. Natl. Acad. Sci. USA 101 (2004) 17765-17770
17. Röijer E., Nordkvist A., Ström A.K., Ryd W., Behrendt M., Bullerdiek J., et al. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. Am. J. Pathol. 160 (2002) 433-440
18. Olofsson A., Willen H., Göransson M., Engström K., Meis-Kindblom J.M., Stenman G., et al. Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas. Int. J. Oncol. 25 (2004) 1349-1355
19. Italiano A., Cardot N., Dupre F., Monticelli I., Keslair F., Piche M., et al. Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the "missing link" between lipomas and liposarcomas?. Int. J. Cancer 121 (2007) 308-315
20. Bartuma H., Hallor K.H., Panagopoulos I., Collin A., Rydholm A., Gustafson P., et al. Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype. Genes Chromosomes Cancer 46 (2007) 594-606
21. Meza-Zepeda L.A., Berner J.M., Henriksen J., South A.P., Pedeutour F., Dahlberg A.B., et al. Ectopic sequences from truncated HMGIC in liposarcomas are derived from various amplified chromosomal regions. Genes Chromosomes Cancer 31 (2001) 264-273
22. Decker C.J., and Parker J. Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr. Opin. Cell. Biol. 7 (1995) 386-392
23. Jousse C., Bruhat A., Carraro V., Urano F., Ferrara M., Ron D., et al. Inhibition of CHOP translation by a peptide encoded by an open reading frame localized in the chop 5'UTR. Nucleic Acids Res. 29 (2001) 4341-4351
24. Meek D.W., and Knippschild U. Posttranslational modification of MDM2. Mol. Cancer Res. 1 (2003) 1017-1026
25. Park J.H., and Roeder R.G. GAS41 is required for repression of the p53 tumor suppressor pathway during normal cellular proliferation. Mol. Cell. Biol. 26 (2006) 4006-4016
26. Llanos S., Efeyan A., Monsech J., Dominguez O., and Serrano M. A high-throughput loss-of-function screening identifies novel p53 regulators. Cell Cycle 5 (2006) 1880-1885
27. Fischer U., Heckel D., Michel A., Janka M., Hulsebos T., and Meese E. Cloning of a novel transcription factor-like gene amplified in human glioma including astrocytoma grade I. Hum. Mol. Genet. 6 (1997) 1817-1822
28. Pentimalli F., Dentice M., Fedele M., Pierantoni G.M., Cito L., Pallante P., et al. Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2. Cancer Res. 63 (2003) 7423-7427
29. Tang Q.Q., and Lane M.D. Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-beta during adipogenesis. Proc. Natl. Acad. Sci. USA 97 (2000) 12446-12450
30. Perez-Losada J., Sanchez-Martin M., Rodriguez-Garcia M.A., Perez-Mancera P.A., Pintado B., and Flores T. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma. Oncogene 19 (2000) 6015-6022
31. Perez-Losada J., Pintado B., Gutierrez-Adan A., Flores T., Banares-Gonzalez B., del Campo J.C., et al. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 19 (2000) 2413-2422
32. Nilsson K., and Landberg G. Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-inactivated tumor cells. Int. J. Cancer 118 (2006) 1120-1125
33. Le Cam L., Polanowska J., Fabbrizio E., Olivier M., Philips A., Ng Eaton E., et al. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J. 18 (1999) 1878-1890
34. Philips A., Huet X., Plet A., Le Cam L., Vié A., and Blanchard J.M. The retinoblastoma protein is essential for cyclin A repression in quiescent cells. Oncogene 16 (1998) 1373-1381
35. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., and Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98 (1999) 859-869
36. Forus A., D'Angelo A., Henriksen J., Merla G., Maelandsmo G.M., Flørenes V.A., et al. Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity. Oncogene 20 (2001) 6881-6890
37. Meza-Zepeda L.A., Forus A., Lygren B., Dahlberg A.B., Godager L.H., South A.P., et al. Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene 21 (2002) 2261-2269
38. Forus A., Larramendy M.L., Meza-Zepeda L.A., Bjerkehagen B., Godager L.H., Dahlberg A.B., et al. Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. Cancer Genet. Cytogenet. 125 (2001) 100-111
39. Okada K., Komuta K., Hashimoto S., Matsuzaki S., Kanematsu T., and Koji T. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis. Clin. Cancer Res. 6 (2000) 3560-3564
40. Houston A., and O'Connell J. The Fas signalling pathway and its role in the pathogenesis of cancer. Curr. Opin. Pharmacol. 4 (2004) 321-326
41. Tani M., Shindo-Okada N., Hashimoto Y., Shiroishi T., Takenoshita S., and Nagamachi Y. Isolation of a novel Sry-related gene that is expressed in high-metastatic K-1735 murine melanoma cells. Genomics 39 (1997) 30-37
42. Wegner M., and Stolt C.C. From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci. 28 (2005) 583-588
43. Wabitsch M., Bruderlein S., Melzner I., Braun M., Mechtersheimer G., and Moller P. LiSa-2, a novel human liposarcoma cell line with a high capacity for terminal adipose differentiation. Int. J. Cancer 88 (2000) 889-894
44. Nishio J., Iwasaki H., Ishiguro M., Ohjimi Y., Fujita C., Ikegami H., et al. FU-DDLS-1: conventional and molecular cytogenetic characterization. Int. J. Oncol. 22 (2003) 535-542
45. Kiguchi K., Ishiwata I., Ishiwata E., Koshitaka Y., Ohara T., Okudai Y., et al. Establishment and characterization of a human liposarcoma cell line (HTLS) from the retroperitoneal liposarcoma. Hum. Cell 18 (2005) 45-52